Patient Priorities in Vasculitis

Shifa Sarica, Neil Basu

Research output: Contribution to journalAbstract

Abstract

The primary systemic vasculitides (PSVs) are a group of complex inflammatory disorders which may affect multiple diverse organs at any one time. The application of immunosuppressive
therapy since the 1970s has transformed the natural history of many of these diseases from once invariably fatal to now chronic relapsing conditions. However, these diseases remain associated with a substantial health burden due to long term toxic therapies and accumulated organ damage.
Original languageEnglish
Pages (from-to)6-8
Number of pages3
JournalNephron
Volume129
Issue numberSuppl. 2
DOIs
Publication statusPublished - Apr 2015
Event17th International Vasculitis & ANCA Workshop - London, United Kingdom
Duration: 19 Apr 201522 Apr 2015

Fingerprint

Vasculitis
Systemic Vasculitis
Poisons
Natural History
Health
Therapeutics

Cite this

Sarica, S., & Basu, N. (2015). Patient Priorities in Vasculitis. Nephron, 129(Suppl. 2 ), 6-8. https://doi.org/10.1159/000381120

Patient Priorities in Vasculitis. / Sarica, Shifa; Basu, Neil.

In: Nephron, Vol. 129, No. Suppl. 2 , 04.2015, p. 6-8.

Research output: Contribution to journalAbstract

Sarica, S & Basu, N 2015, 'Patient Priorities in Vasculitis', Nephron, vol. 129, no. Suppl. 2 , pp. 6-8. https://doi.org/10.1159/000381120
Sarica S, Basu N. Patient Priorities in Vasculitis. Nephron. 2015 Apr;129(Suppl. 2 ):6-8. https://doi.org/10.1159/000381120
Sarica, Shifa ; Basu, Neil. / Patient Priorities in Vasculitis. In: Nephron. 2015 ; Vol. 129, No. Suppl. 2 . pp. 6-8.
@article{f7e5a724763a48839967e513356bce50,
title = "Patient Priorities in Vasculitis",
abstract = "The primary systemic vasculitides (PSVs) are a group of complex inflammatory disorders which may affect multiple diverse organs at any one time. The application of immunosuppressivetherapy since the 1970s has transformed the natural history of many of these diseases from once invariably fatal to now chronic relapsing conditions. However, these diseases remain associated with a substantial health burden due to long term toxic therapies and accumulated organ damage.",
author = "Shifa Sarica and Neil Basu",
year = "2015",
month = "4",
doi = "10.1159/000381120",
language = "English",
volume = "129",
pages = "6--8",
journal = "Nephron Experimental Nephrology",
issn = "1660-2129",
publisher = "S. Karger AG",
number = "Suppl. 2",

}

TY - JOUR

T1 - Patient Priorities in Vasculitis

AU - Sarica, Shifa

AU - Basu, Neil

PY - 2015/4

Y1 - 2015/4

N2 - The primary systemic vasculitides (PSVs) are a group of complex inflammatory disorders which may affect multiple diverse organs at any one time. The application of immunosuppressivetherapy since the 1970s has transformed the natural history of many of these diseases from once invariably fatal to now chronic relapsing conditions. However, these diseases remain associated with a substantial health burden due to long term toxic therapies and accumulated organ damage.

AB - The primary systemic vasculitides (PSVs) are a group of complex inflammatory disorders which may affect multiple diverse organs at any one time. The application of immunosuppressivetherapy since the 1970s has transformed the natural history of many of these diseases from once invariably fatal to now chronic relapsing conditions. However, these diseases remain associated with a substantial health burden due to long term toxic therapies and accumulated organ damage.

U2 - 10.1159/000381120

DO - 10.1159/000381120

M3 - Abstract

VL - 129

SP - 6

EP - 8

JO - Nephron Experimental Nephrology

JF - Nephron Experimental Nephrology

SN - 1660-2129

IS - Suppl. 2

ER -